Rapacan 1 mg Tablets

Sirolimus, also known as Rapamycin, is an immunosuppressive medication primarily used to prevent organ rejection in patients who have received a kidney transplant. It works by inhibiting a specific protein called mTOR, which plays a key role in the activation and proliferation of immune cells that could otherwise attack the newly transplanted organ. By calming this immune response, Sirolimus helps the body accept the new organ and supports its long-term function and health. It is often used in combination with other immunosuppressive therapies as part of a carefully balanced treatment plan tailored to each transplant recipient. Beyond transplant medicine, Sirolimus has also found valuable applications in treating certain rare conditions, including lymphangioleiomyomatosis, a lung disease, and has been used in specialized coatings for cardiac stents to help keep blood vessels open. It is taken orally, typically once daily, allowing for consistent and manageable dosing at home. Doctors closely monitor blood levels of the medication to ensure it stays within an effective and safe range for each individual patient. Its introduction has been an important advancement in transplant medicine, helping improve graft survival rates and quality of life for transplant recipients. Many patients have benefited from the stability and peace of mind that comes with effective, long-term immunosuppressive therapy. With appropriate medical supervision, Sirolimus continues to play a trusted role in helping patients lead full, active lives after transplantation.